Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 2Phase 2 1

Status

Completed 20Recruiting 7Terminated 4Active not recruiting 2Unknown 1No longer available 1

Sponsor Class

INDUSTRY 6OTHER 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Other solid neoplasm 7

Conditions

Breast Neoplasms 1789Neoplasms 1516Carcinoma, Non-Small-Cell Lung 1053Prostatic Neoplasms 965Colorectal Neoplasms 889Lung Neoplasms 809Pancreatic Neoplasms 583Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 540Stomach Neoplasms 523Ovarian Neoplasms 513Neoplasm Metastasis 492Multiple Myeloma 491Recurrence 417Melanoma 390Squamous Cell Carcinoma of Head and Neck 374Uterine Cervical Neoplasms 366Brain Neoplasms 364Head and Neck Neoplasms 355Esophageal Neoplasms 320Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Endometrial Neoplasms 311Lymphoma 309Triple Negative Breast Neoplasms 301Glioblastoma 298Rectal Neoplasms 284Urinary Bladder Neoplasms 268Sarcoma 266Hematologic Neoplasms 266Colonic Neoplasms 257

Interventions

Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Recruiting × Solid Tumours × Clear all
NCT07446855 2026-05-26

PARTHENON

AstraZeneca

Phase 1/2 Recruiting
180 enrolled
Other solid neoplasm

Solid Tumours

NCT07160725 2026-05-15

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

Bristol-Myers Squibb

Phase 1/2 Recruiting
315 enrolled
Other solid neoplasm

Solid Tumours

NCT06725758 2026-05-08

TEADES

Orion Corporation, Orion Pharma

Phase 1/2 Recruiting
315 enrolled
Other solid neoplasm

Solid Tumours

NCT06581432 2026-04-29

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Boehringer Ingelheim

Phase 2 Recruiting
430 enrolled
Other solid neoplasm

Solid Tumours

NCT07165067 2025-12-29

A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors

AP Biosciences Inc.

Phase 1 Recruiting
36 enrolled
Other solid neoplasm

Solid Tumours

NCT06815575 2025-12-17

A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

Racura Oncology Ltd

Phase 1 Recruiting
53 enrolled
Other solid neoplasm

Solid Tumours

NCT03572192 2025-11-18

Tissue Collection Framework To Improve Outcomes In Solid Tumours

Queen Mary University of London

Recruiting
3,000 enrolled
Other solid neoplasm

Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡